ResMed Inc.
RMDResMed Inc. is a healthcare company that specializes in developing, manufacturing, and marketing medical equipment primarily for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Founded in 1989, the company is known for its innovative sleep and respiratory care solutions, including devices such as CPAP machines, ventilators, and related accessories. ResMed operates globally, serving both individual patients and healthcare providers.
Dividend History
Investors can expect a dividend payout of $0.60 per share, scheduled to be distributed in 10 days on December 18, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 18, 2025 | $0.60 | 2025-11-13 | 2025-11-13 |
| September 18, 2025 | $0.60 | 2025-08-14 | 2025-08-14 |
| June 12, 2025 | $0.53 | 2025-05-08 | 2025-05-08 |
| March 20, 2025 | $0.53 | 2025-02-13 | 2025-02-13 |
| December 12, 2024 | $0.53 | 2024-11-07 | 2024-11-07 |
Dividends Summary
- ResMed Inc. has issued 54 dividend payments over the past 13 years
- The most recent dividend was paid 81 days ago, on September 18, 2025
- The highest dividend payed out to investors during this period was $0.60 per share
- The average dividend paid during this period was $0.37 per share.
Company News
Nyxoah secured $77 million in financing through a private placement, registered direct offering, and convertible bond to support U.S. commercialization of its Genio system for treating Obstructive Sleep Apnea (OSA).
ResMed reported strong Q3 results with double-digit EPS growth and a tariff exemption, leading analysts to boost their price forecasts for the company.
ResMed, a leader in sleep apnea and respiratory care solutions, reported robust fiscal 2025 second-quarter earnings, surpassing analyst expectations. The strong performance was driven by high demand for sleep-related products and growth in digital health solutions.
ResMed reported revenue of $1.22 billion and EPS of $2.08 for Q2 2024, beating analyst estimates. The company saw growth across its various business segments, including devices, masks, and software as a service.
